First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RB201 in Healthy Adult Subjects

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: e17b124eb345807fcfba6415939c9895661760a9
First added on: Apr 23, 2026